IDYA
IDEAYA Biosciences Inc.
Company Overview
| Mkt Cap | $2.26B | Price | $31.86 |
| Volume | 1.03M | Change | +0.82% |
| P/E Ratio | -8.2 | Open | $31.54 |
| Revenue | $7.0M | Prev Close | $31.60 |
| Net Income | $-274.5M | 52W Range | $13.45 - $33.64 |
| Div Yield | N/A | Target | $47.88 |
| Overall | 63 | Value | 60 |
| Quality | -- | Technical | 66 |
No chart data available
Stock Overview
Updated DailyIDEAYA Biosciences Inc. (IDYA) is a leading Healthcare company in the Biotechnology industry, currently trading at $31.86 with a market capitalization of $2.26 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows IDYA with a volume of 1.03 million shares. The stock opened down 0.19% from yesterday's close of $31.60. Current analyst estimates project earnings of $-2.68 per share for this year, with next year targeting $-3.54.
IDYA demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for IDYA include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 50.3%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 11:03 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IDYA | $31.86 | +0.8% | 1.03M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |